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Abstract
Background: There is growing acceptance that polycystic ovaries are an important marker of
polycystic ovary syndrome (PCOS) despite significant variability when making the ultrasound
diagnosis. To better understand the nature of this variability, we proposed to evaluate the level of
inter-observer agreement when identifying and quantifying individual ultrasonographic features of
polycystic ovaries.
Methods: Digital recordings of transvaginal ultrasound scans performed in thirty women with
PCOS were assessed by four observers with training in Radiology or Reproductive Endocrinology.
Observers evaluated the scans for: 1) number of follicles ≥ 2 mm per ovary, 2) largest follicle
diameter, 3) ovarian volume, 4) follicle distribution pattern and 5) presence of a corpus luteum
(CL). Lin's concordance correlation coefficients and kappa statistics for multiple raters were used
to assess inter-observer agreement.
Results: Agreement between observers ranged from 0.08 to 0.63 for follicle counts, 0.27 to 0.88
for largest follicle diameter, 0.63 to 0.86 for ovarian volume, 0.51 to 0.76 for follicle distribution
pattern and 0.76 to 0.90 for presence of a CL. Overall, reproductive endocrinologists
demonstrated better agreement when evaluating ultrasonographic features of polycystic ovaries
compared to radiologists (0.71 versus 0.53; p = 0.04).
Conclusion:  Inter-observer agreement for assessing ultrasonographic features of polycystic
ovaries was moderate to poor. These findings support the need for standardized training modules
to characterize polycystic ovarian morphology on ultrasonography.
Background
Polycystic ovary syndrome (PCOS) is a common endo-
crine disorder of unknown cause [1]. Epidemiological
studies have estimated a prevalence of 6.5 to 8% using
biochemical and/or clinical evidence [1] while studies
involving ultrasonographic evidence of polycystic ovaries
have reported a prevalence of 20% or more [2]. PCOS is
characteristically heterogeneous in its clinical presenta-
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tion and therefore, much debate remains regarding con-
sensus diagnostic criteria for the syndrome [3].
Historically, the combination of androgen excess and
oligo-amenorrhea has been considered the hallmark of
PCOS by North American standards [4]. By contrast, Brit-
ish and European standards have based the diagnosis pri-
marily on ultrasonographic evidence of polycystic ovaries
[5]. Clarifying diagnostic criteria for PCOS has significant
implications for the early identification and intervention
of this condition. Early diagnosis and intervention is war-
ranted since there is considerable evidence that women
with PCOS are at increased risk for infertility, dysfunc-
tional uterine bleeding, metabolic syndrome, type II dia-
betes and cardiovascular disease [6,7]. There is also
growing evidence for increased risk of obstructive sleep
apnea, depression, nonalcoholic fatty liver disease and
certain cancers [8-11].
In 2003, ultrasonographic evidence of polycystic ovaries
was formally incorporated as a diagnostic marker of PCOS
at a joint meeting of the European Society for Human
Reproduction and Embryology (ESHRE) and the Ameri-
can Society for Reproductive Medicine (ASRM) [6,7].
Inclusion of an ovarian marker was based on substantial
evidence that most women who presented with clinical
and biochemical features of PCOS had polycystic ovaries
on ultrasound [12-14]. The current ultrasound guidelines
supported by ESHRE/ASRM consensus characterize the
polycystic ovary as containing 12 or more follicles meas-
uring 2 – 9 mm and/or an increased ovarian volume of
>10 cm3 [15]. Unlike the widely used criteria previously
proposed by Adams and colleagues [16], a subjective
assessment of stromal echogenicity and follicle distribu-
tion pattern is not included. The cutoff value for an
increased ovarian volume was derived from cumulative
reports of a larger mean volume for polycystic ovaries
compared to a mean volume of <10 cm3 for normal ova-
ries [17]. The cutoff of ≥12 follicles throughout the entire
ovary, and not a single plane, was based on a report dem-
onstrating this value to have 99% specificity and 75% sen-
sitivity in distinguishing between polycystic and normal
ovaries in women of reproductive age [15].
While there is growing agreement that polycystic ovaries
represent an important component of the clinical presen-
tation of PCOS, it is important to acknowledge that signif-
icant inter- and intra-observer variability has been
reported when making the ultrasound diagnosis [18]. In
an analysis of 54 ovarian scans in which images of 27
polycystic and normal ovaries were duplicated and rand-
omized for post-hoc evaluation by four experienced
observers, a diagnosis of polycystic ovarian morphology
was agreed upon only 51% of the time while observers
agreed with himself/herself only 69% of the time [18]. In
their study, Amer et al. defined the polycystic ovary as hav-
ing ≥10 follicles (2 – 8 mm) in a single plane, an ovarian
volume ≥12 cm3 and a bright echogenic stroma. The high
degree of variability in making the diagnosis suggested
that the ultrasound criteria employed were either too sub-
jective or too insensitive to allow for good agreement
among observers [17]. The extent to which any of the
ultrasound criteria contributed to the subjectivity of the
diagnosis was not assessed and to date, we are unaware of
any other study that has attempted to further evaluate sub-
jectivity in the ultrasound diagnosis of polycystic ovaries.
In the present study, we attempted to determine where
discrepancies in the evaluation of polycystic ovaries might
lie by determining the level of inter-observer agreement
associated with the assessment of individual ultrasono-
graphic aspects of polycystic ovarian morphology such as
total follicle count, largest follicle diameter, ovarian vol-
ume, follicle distribution pattern and presence of a corpus
luteum. Given past reports of significant variability in
diagnosing polycystic ovaries, we hypothesized that agree-
ment when evaluating ultrasonographic features of poly-
cystic ovaries would be poor even among experienced
medical imaging specialists with training in Radiology or
Reproductive Endocrinology.
Methods
Study subjects
Thirty women diagnosed with PCOS using the 2003 inter-
national consensus guidelines [6,7] of having two of three
characteristics: 1) oligo- or anovulation (menstrual cycles
<21 or >38 days)[19], 2) clinical and/or biochemical evi-
dence of hyperandrogenism (modified Ferriman-Gallwey
score ≥ 8 [20] and/or a free androgen index ≥ 4 [21]), 3)
polycystic ovaries on ultrasound (≥12 follicles measuring
2 – 9 mm in diameter or an ovarian volume >10 cm3)[17],
were enrolled in the study. Subjects ranged in age from 18
to 35 and could not have used hormonal contraception,
fertility medications or valproate in the three months
prior to enrolment. Subjects were screened for the absence
of hyperprolactinemia, hypercortisolemia, thyroid dys-
function and 21-hydroxylase deficiency. The ability to vis-
ualize at least one ovary by transvaginal ultrasonography
was required for inclusion in the study.
Transvaginal ultrasonography
A single transvaginal ultrasound scan was performed at a
random time (during the menstrual cycles) in subjects
reporting absent, irregular or regular periods. Scans were
performed by a single ultrasonographer using an UltraSo-
nix RP ultrasound scanner equipped with a 9-MHz trans-
vaginal transducer (UltraSonix, Version 2.3.5, Vancouver,
BC). Each ovary was visualized and anatomic orientation
with respect to the utero-ovarian ligament was estab-
lished. Ovaries were scanned from the inner to outer mar-
gins in both the transverse and sagittal planes. Real-timeJournal of Ovarian Research 2009, 2:6 http://www.ovarianresearch.com/content/2/1/6
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ultrasound scans were digitally recorded (i.e., audio-video
interleaved file format) and files later transferred to a cus-
tom-designed database for post-hoc image analysis.
Randomization of ultrasonographic image files
Digital video clips of thirty individual ovaries (one from
each subject) were selected for analysis from the sixty ova-
ries scanned. All video clips selected for the inter-observer
analysis were judged by two raters to have good or excel-
lent resolution of the ovary prior to inclusion. Each ovar-
ian case study was designated an electronic folder on the
database and each folder contained two digital video clips
of the ovary in question – one clip represented a sweep
through the ovary in the transverse plane and the other
represented a sweep through the ovary in the sagittal
plane. Links to these thirty folders were randomly gener-
ated for each of the four observers such that no observer
reviewed the folders in the same order.
Evaluation of ultrasonographic image files
Two senior Radiology residents (PGY 4 and PGY 5) and
two clinician/scientists with training in Reproductive
Endocrinology (a clinical reproductive endocrinologist
and a fellow with training in transvaginal ultrasonogra-
phy) reviewed the folders at computer workstations for
the following primary endpoints: 1) total follicle count,
2) largest follicle diameter, 3) ovarian volume, 4) follicle
distribution pattern and 5) presence of a corpus luteum
(CL). For the follicle count endpoint, observers were
asked to count the total number of follicles ≥ 2 mm in the
entire ovary using one of the two video clips provided (i.e.
clearly labeled "for follicle counts"). Observers were
instructed to use both video clips to select the follicle with
the largest diameter and to designate follicle distribution
pattern. For the follicle distribution pattern endpoint,
observers were to judge whether follicles in the ovary were
predominantly distributed in a "peripheral" pattern or
whether follicles were distributed more heterogeneously
("even") throughout the stroma. In instances where they
felt that neither category could best describe the distribu-
tion pattern, a designation of "other" could be assigned.
Observers were asked to calculate ovarian volume using
the equation for a prolate spheroid [22] from measure-
ments of the largest and widest diameters of the ovaries in
the transverse and sagittal planes. Lastly, observers were
instructed to determine the presence or absence of a cor-
pus luteum using both video clips. Two complementary
software programs (FRAME© and SYNERGYNE 2©, Saska-
toon, SK, Canada) were used to analyze the digital record-
ings. Video clips could be viewed at any speed or in
direction including, frame-by-frame analysis. Colour/con-
trast adjustments and linear measurements could also be
made on any frame of the video clip.
Ethical considerations
This study was approved by the University of Saskatch-
ewan Biomedical Research Ethics Review Board. All study
procedures conformed to the Canadian Tri-Council
Guidelines for Human Research and International Good
Clinical Practice Guidelines. Informed consent was
obtained from all study subjects.
Statistical analyses
Descriptive statistics (mean ± SEM) for clinical, hormonal
and metabolic features of the study subjects were garnered
from clinical and laboratory medical records obtained at
the time of evaluation for PCOS. Mean (± SEM) measure-
ments of follicle counts, maximum follicle diameter and
ovarian volume were tabulated and compared among
observers using Tukey-Kramer's multiple comparisons
tests and paired t-tests. Lin's concordance correlation coef-
ficients (ρ) were used to assess inter-observer agreement
for continuous measures [23] and kappa statistics for mul-
tiple raters (κ) were used to assess inter-observer agree-
ment for discrete measures [24]. P and κ values that
approximated 1 denoted perfect agreement, while values
that approximated 0 denoted agreement no better than
that by chance. Guidelines for evaluating level of agree-
ment among scores were: >0.80 good, 0.60 – 0.80 moder-
ate/fair, <0.60 poor [25].
Results
Subject demographics
Clinical, hormonal and metabolic features of the study
participants are presented in Table 1. The average age of
the participants was 28.3 ± 0.9 years and their mean BMI
and waist circumference was 29.6 ± 1.3 kg/m2 and 93.7 ±
2.7 cm, respectively. Forty-three percent of study subjects
were obese (>30 kg/m2), 17% were overweight (26 – 30
kg/m2) and 40% were lean (≤25 kg/m2). Thirty-three per-
cent of subjects reported menstrual cycles every 21 – 38
days, 30% reported cycles every 39 – 90 days and 37%
reported cycles >90 days apart. Eighty-seven percent of
subjects had elevated scores for hirsutism and/or an
increased free androgen index. Only 13% of participants
showed no clinical or biochemical signs of androgen
excess. One subject demonstrated a mild case of impaired
fasting glycemia (6.1 mmol/L) whereas the remaining
participants demonstrated normal fasting glucose levels.
Thirty percent of subjects were however, subsequently
designated as insulin resistant as judged by an increased
homeostatic model assessment of insulin resistance value.
Continuous measures
Mean (± SEM) measurements for total follicle count, larg-
est follicle diameter and ovarian volume reported by the
four observers are compared in Table 2. Overall, the aver-
age number of follicles counted by the four observer was
33.5 ± 1.7, the mean largest follicle diameter was 8.0 ± 0.6Journal of Ovarian Research 2009, 2:6 http://www.ovarianresearch.com/content/2/1/6
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mm and the mean ovarian volume was 10.1 ± 0.5 cm3.
Follicle counts varied among the four observers (p <
0.0001) with Observer 3 making significantly lower
counts compared to each of the other three observers (p <
0.001). Largest follicle diameter (p = 0.090) and ovarian
volume measurements (p = 0.650) did not differ among
observers. When measurements were stratified for radiol-
ogists and reproductive endocrinologists, radiologists
made lower follicle counts (27.6 ± 1.8 vs. 39.4 ± 2.0, p <
0.0001) and larger measurements for maximum follicle
diameter (8.6 ± 0.4 vs. 7.4 ± 0.4, p = 0.003) and ovarian
volume (10.5 ± 0.5 vs. 9.6 ± 0.6, p = 0.018) compared to
reproductive endocrinologists.
Scatter plots of pair-wise agreement in follicle counts,
largest follicle diameter measurements and ovarian vol-
ume calculations by four observers are presented in Figure
1. Perfect agreement between two observers corresponds
to a slope of 1 (diagonal line). Inter-observer agreement
was best for ovarian volume followed by largest follicle
diameter and total follicle count, as judged by the pre-
dominance of points aggregating along the diagonal line.
The corresponding levels of agreement among the
observer pairs are summarized in Table 3. Agreement
between observers ranged from 0.08 to 0.63 for follicle
counts, 0.27 to 0.88 for largest follicle diameter and 0.63
to 0.86 for ovarian volume. Evaluators with training in
Reproductive Endocrinology (represented by Observer
Pair 1,4) demonstrated better agreement in follicle counts
(0.27 vs. 0.16), largest follicle diameter (0.86 vs. 0.43)
and ovarian volume (0.84 vs. 0.75) compared to those
with training in general Radiology (represented by
Observer Pair 2,3), respectively. In general, decreased lev-
els of agreement were evident for the follicle count and
largest follicle diameter endpoints when comparisons
were made with Observer 3. Overall, inter-observer agree-
ment was poor for continuous measures (overall ρ = 0.55)
Discrete measures
The level of agreement when assigning follicle distribu-
tion pattern and the presence of a CL is summarized in
Table 3. Agreement between observers ranged from 0.51
to 0.76 for follicle distribution pattern and 0.76 to 0.90
for presence of a CL. Overall, inter-observer agreement
was moderate for discrete measures (overall κ = 0.73).
Evaluators with training in Reproductive Endocrinology
(represented by Observer Pair 1,4) demonstrated better
agreement when designating follicle distribution pattern
Table 1: Clinical, hormonal and metabolic features of PCOS study subjects
Mean ± SEM Range Normal Values
Age (yr) 28.3 ± 0.9 19 – 35 -
BMI (kg/m2) 29.6 ± 1.3 19.4 – 45.0 20 – 25
Waist Circumference (cm) 93.7 ± 2.7 70.0 – 123.0 < 88
Menstrual Cycle Length (d) 91.3 ± 15.0 28 – 365 21 – 38
LH:FSH 2.4 ± 0.3 0.6 – 7.6 < 2
mFG Score 9.3 ± 1.0 0 – 24 <8
Testosterone (nmol/L) 2.3 ± 0.2 1.0 – 5.0 < 2.5
SHBG (nmol/L) 45.9 ± 3.9 13.0 – 95.3 18 – 114
Free Androgen Index 6.2 ± 0.7 1 – 19 < 5
DHEA-S (μmol/L) 4.8 ± 0.3 1.8 – 8.8 0.9 – 12.0
Fasting Glucose (mmol/L) 4.8 ± 0.1 4.2 – 6.1 < 6.1
Fasting Insulin (pmol/L) 78.3 ± 10.4 21.0 – 205.0 14.0 – 100.0
HOMA-IR 2.9 ± 0.4 0.7 – 8.1 < 3
Normative values for the local health region are provided. Body mass index (BMI), luteinizing hormone (LH), follicle stimulating hormone (FSH), 
modified Ferriman-Gallwey (mFG), sex hormone binding globulin (SHBG), dehydroepiandrosterone sulfate (DHEA-S), homeostatic model 
assessment of insulin resistance (HOMA-IR).
Table 2: Ultrasonographic measurements of polycystic ovaries made by four observers
Observers
123 4
Follicle Count 33.8 ± 1.6a 36.9 ± 2.5a, c 18.3 ± 1.0b 44.9 ± 3.3c
Largest Follicle (mm) 7.3 ± 0.6a 8.0 ± 0.6a 9.3 ± 0.6a 7.4 ± 0.5a
Ovarian Volume (cm3) 9.7 ± 0.8a 10.3 ± 0.8a 10.7 ± 0.8a 9.4 ± 0.9a
Significant differences for within row comparisons are denoted by different letters (p < 0.05). Observers 1 and 4 represent measurements made by 
reproductive endocrinologists. Observers 2 and 3 represent measurements made by radiologists.Journal of Ovarian Research 2009, 2:6 http://www.ovarianresearch.com/content/2/1/6
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Scatter plots of total follicle counts (A), largest follicle diameter measurements (B) and ovarian volume calculations (C) by all  possible pair-wise combinations of the four observers are presented Figure 1
Scatter plots of total follicle counts (A), largest follicle diameter measurements (B) and ovarian volume calcu-
lations (C) by all possible pair-wise combinations of the four observers are presented. Perfect agreement between 
two observers corresponds to a slope of 1 (represented by the diagonal line). Inter-observer agreement was best for ovarian 
volume and poorest for total follicle counts.
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(0.76 vs. 0.51) and presence of a CL (0.86 vs. 0.80) com-
pared to those with training in general Radiology (repre-
sented by Observer Pair 2,3), respectively.
Discussion
Our results showed that despite reproductive endocrinol-
ogists demonstrating better agreement than radiologists
when evaluating ultrasonographic features of polycystic
ovaries, overall inter-observer agreement for both groups
was only moderate to poor. In the case of counting the
total number of follicles throughout the entire ovary,
agreement was alarmingly poor. This was in contrast to
past reports of good agreement when multiple observers
counted follicles using both real-time and stored transvag-
inal ultrasonographic imaging [26-28]. Good agreement
in these studies was associated with counts that approxi-
mated 10 follicles per ovary [26,28]. In our current study,
women diagnosed with PCOS by the ESHRE/ASRM crite-
ria had counts that were generally in the order of 30 – 35
follicles. That we were counting more than three times as
many follicles per ovary likely explains the lower levels of
reliability reported by our group. The poor level of agree-
ment for counting follicles may be interpreted to mean
that follicle counts are too unreliable to be diagnostic.
However, it is important to recognize that the current
ultrasound guidelines only necessitate the ability to relia-
bly count 12 follicles throughout the entire ovary [15].
Our data showed that observers were consistent in identi-
fying at least 12 follicles per ovary; yet we were interested
in assessing the reliability of total follicle counts since
recent studies have suggested that a significantly higher
threshold than 12 is needed to adequately discriminate
between polycystic and normal ovaries [29]. Moreover,
there is emerging evidence that ovarian morphology may
reflect the degree of reproductive and metabolic distur-
bance in PCOS and therefore, give insight into the pro-
gression of the syndrome within an individual patient
[30]. Future studies aimed at improving reliability in fol-
licle counts will be needed to verify the validity and appli-
cability of this ultrasonographic endpoint in the
evaluation of PCOS.
In contrast to follicle counts, agreement when calculating
ovarian volume was fair. This observation was consistent
with several studies reporting good agreement when mul-
tiple observers assessed ovarian volume by ultrasonogra-
phy [27,31-34]. Better agreement when calculating
ovarian volume suggests that this endpoint may serve as a
more reliable marker of polycystic ovaries than follicle
counts. Unfortunately, there is significant debate regard-
ing the sensitivity of increased ovarian volume as a diag-
nostic criterion for polycystic ovaries. The currently
accepted cutoff of >10 cm3 was associated with 98.2% spe-
cificity, but only 45% sensitivity, in discriminating
between normal and polycystic ovaries [35]. Since 2003,
both a lower threshold of 7 cm3 [35] and a higher thresh-
old 13 cm3 [29] have been proposed as being more appro-
priate thresholds for polycystic ovarian morphology.
Some of the controversy over a reliable diagnostic cut-off
likely relates to inconsistent methods for determining
ovarian volume. There is currently no consensus on the
most suitable method of approximating ovarian volume.
Clinicians and researchers use a myriad of techniques
ranging from semi-automated volumetric task functions
offered by conventional ultrasound systems to manual
calculations using linear measurements made in multiple
cross-sectional images. In the present study, we employed
the equation for a prolate spheroid, rather than the com-
monly used equation of a prolate ellipsoid, since this
method was found to correlate better with volume meas-
urements of polycystic ovaries made by 3D ultrasound
[22].
Historically, the peripheral distribution of follicles has
been considered a hallmark of polycystic ovaries [16]. The
classic "string of pearls" appearance is embedded in the
Medical Imaging literature and remains highly remarked
upon in radiological reports confirming the presence of
Table 3: Level of pair-wise agreement among four observers assessing ultrasonographic features of polycystic ovaries
Concordance Correlation Coefficient Kappa Statistic
Observer Pair Follicle Count Largest Follicle Ovarian Volume Average Follicle Pattern Corpus Luteum Average
1,2 0.63 0.88 0.86 0.79 0.66 0.90 0.78
1,3 0.18 0.27 0.80 0.42 0.58 0.76 0.67
1,4 0.27 0.86 0.84 0.66 0.76 0.86 0.81
2,3 0.16 0.43 0.75 0.44 0.51 0.80 0.65
2,4 0.48 0.86 0.67 0.67 0.73 0.83 0.78
3,4 0.08 0.34 0.63 0.35 0.54 0.83 0.69
Average 0.30 0.61 0.76 0.55 0.63 0.83 0.73
Observer Pair 1,4 represent measurements made by reproductive endocrinologists, Observer Pair 2,3 represent measurements made by 
radiologists.Journal of Ovarian Research 2009, 2:6 http://www.ovarianresearch.com/content/2/1/6
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polycystic ovarian morphology. In the current study,
determination of follicle pattern among observers was
poor. Difficulty assigning follicle pattern may have related
to confusion over the most appropriate ovarian cross-sec-
tion in which to make the determinations since observers
were analyzing digital recording rather than static images.
Moreover, there may have been reluctance to assign folli-
cle pattern in the presence of a dominant follicle or CL.
We were unable to find any study reporting specific relia-
bility coefficients when assigning follicle pattern using
static or dynamic transvaginal ultrasonography [17].
While the current ultrasound criteria for polycystic ovaries
exclude an assessment of follicle pattern, the appropriate-
ness of its omission as a diagnostic criterion is questiona-
ble. Recently, a surrogate and more objective measure of
follicle pattern, called the stromal-total area ratio, was
shown to have 100% specificity and 100% sensitivity in
diagnosing polycystic ovaries [36]. This group also
recently reported good reliability among observers when
making calculations of the stromal-total area ratio [37].
We suspect that wider adoption of this criterion may occur
in light of favorable reports pertaining to its ease of use in
clinical practice [37].
Agreement in the identification of CL was good among
observers. Disagreement among observers was generally
noted only when a CL appeared as a cystic structure rather
than a hyperechoic structure with a small to negligible
fluid-filled cavity [38]. In these instances, there was a ten-
dency to mistake a CL for a dominant follicle (i.e.,
accounting for outlier measurements for the largest folli-
cle diameter endpoint). Identifying the presence of CL is a
highly important finding given its implications for infer-
tility and risk of endometrial hyperplasia. However, it has
been our experience that very few ultrasound reports com-
ment on the presence or absence of a CL leading one to
suspect that identification of ovulatory structures is not
part of routine radiological assessments for many prac-
tices. While CL are generally present during the luteal
phase, it is important to note that CL (albeit non-func-
tional) can be visualized ultrasonographically during the
early follicular phase [38]. This coincides with the recom-
mended time for the ultrasonographic evaluation of
PCOS [17]. Given growing recognition that some women
with PCOS demonstrate regular menses, it is important to
corroborate any evidence of ovulation to ascertain poten-
tially lower health risks in this discrete subset of patients
[39].
While it is tempting to conclude that levels of agreement
reported in this study were due to differences in experi-
ence (i.e., three of four observers were trainees), it is
important to recognize that all observers were deemed
experienced gynecological ultrasonography. In the case of
the radiologists, both were senior Radiology residents that
had fulfilled the ultrasonographic requirements for their
training programs and were scheduled to enter general
practice in less than a year. In the case of the reproductive
endocrinologists, one was a gynecologist with more than
twenty years of ultrasonography experience while the
other was a fellow who at the time of the study had more
than 18 months of intensive training in ovarian ultra-
sonography. Better agreement among reproductive endo-
crinologists could be due to the fact that both were
working together at the same institution, in an area of
study where there was greater likelihood of encountering
polycystic ovarian morphology. Nevertheless, it should be
noted that overall levels of agreement were highest among
Observers 1 and 2 – a reproductive endocrinologist and a
radiologist – suggesting that discipline alone cannot fully
explain the disparity among groups. While Observer 3
may have lessened agreement among radiologists by
undercounting follicles and overestimating follicle size,
this observer's conservative approach surely represents a
subset of Medical Imaging specialists that would interpret
ultrasonographic images of polycystic ovaries in a similar
fashion. Ultimately, this set of observers is representative
of a real-life clinical setting.
In summary, inter-observer agreement for identifying and
quantifying individual ultrasonographic features of poly-
cystic ovaries was moderate to poor. Agreement was best
for the identification of a CL followed by determination of
ovarian volume, largest follicle diameter, follicle distribu-
tion pattern and lastly, total follicle count. While we rec-
ognize that not all of these features are used to diagnose
polycystic ovaries, we believe each of these features
should be evaluated at the time of ovarian ultrasonogra-
phy since each relates to an important aspect of ovarian
physiology. If ultrasonographic evidence of polycystic
ovaries is to be used as an objective measure in the diag-
nosis of PCOS, then decreasing variability in the ultra-
sound diagnosis is crucial. Standardized training modules
for the uniform acquisition and interpretation of ultra-
sonographic images may be a necessary first step toward
improving reliability in identifying polycystic ovarian
morphology.
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